What does this research mean for the field?

Serum creatine phosphokinase (CPK) is a promising, cost-effective biomarker that correlates with organophosphorus poisoning severity, but its clinical utility requires further validation due to specificity issues and limited sample sizes in current studies. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To assess the viability of serum creatine phosphokinase as a biomarker for organophosphate poisoning severity.

May 17, 2026Eurasian Journal of Toxicology0 citationsOpen Access

Serum Creatine Phosphokinase as a Biomarker in Organophosphate Poisoning

MKMürsel KoçerOsmaniye Korkut Ata University

Key Points

To assess the viability of serum creatine phosphokinase as a biomarker for organophosphate poisoning severity.
Evaluated serum CPK levels in patients with organophosphate poisoning.
Correlated CPK levels with severity of poisoning.
Considered factors affecting CPK specificity and levels.
Found a correlation between serum CPK levels and severity of organophosphate poisoning; specifics not detailed.
Identified issues with specificity and the impact of other clinical conditions on CPK levels.
Limited the generalizability of findings due to small sample size, especially in severe cases.

Abstract

Organophosphorus (OP) poisoning is a significant public health problem, particularly in developing countries, and there is a need for accessible biomarkers. This paper evaluates the study entitled “Serum Creatine Phosphokinase as a Biomarker in Organophosphorus Poisoning.” The study's strengths include the correlation between serum creatine phosphokinase (CPK) levels and poisoning severity, and its cost-effectiveness as a test. However, the limited sample size and the small number of patients in the severe poisoning group limit the generalizability of the results. Furthermore, the specificity issues of CPK and concomitant clinical conditions that may affect its levels should be considered. In conclusion, while CPK is a promising biomarker in OP poisoning, more comprehensive studies are needed to clarify its clinical use.

Ask AI

Helpful

Bookmark

View Full Paper